ICN Yugoslavia Unit Could Resume Exports
COSTA MESA —
ICN Pharmaceuticals Inc.’s Galenika Yugoslavia unit would be allowed to resume export operations if United Nations sanctions are lifted against that country. The Costa Mesa drug maker said ICN Galenika’s export operations were valued at $30 million to $40 million before the imposition of the sanctions.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
